ReviewCurrent atherosclerosis reports2015
FXR agonists as therapeutic agents for non-alcoholic fatty liver disease.
Rotonya M Carr et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
64 papers cite itlatest 60 shown
this papertrialcites it
ReviewCurrent atherosclerosis reports2015
Rotonya M Carr et al.PubMed ↗Publisher ↗
No numbers read from the abstract.